Literature DB >> 23356296

Role of extracellular membrane vesicles in intercellular communication of the tumour microenvironment.

Katrin J Svensson1, Mattias Belting.   

Abstract

Over the last few decades, extensive studies by several groups have introduced the concept of cell-derived secreted extracellular membrane vesicles as carriers of complex molecular information. Owing to their pleiotropic biological effects and involvement in a wide variety of biological processes, extracellular membrane vesicles have been implicated in physiological as well as pathological events, including tumour development and metastasis. In the present review, we discuss the role of secreted membrane vesicles in intercellular communication with a focus on tumour biology. Of particular interest is the potential role of extracellular vesicles as orchestrators of common features of the malignant tumour microenvironment, e.g. coagulation activation and angiogenesis.

Entities:  

Mesh:

Year:  2013        PMID: 23356296     DOI: 10.1042/BST20120248

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

1.  piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment.

Authors:  Beibei Li; Jiaxin Hong; Mei Hong; Yajun Wang; Tingting Yu; Sibin Zang; Qiuling Wu
Journal:  Oncogene       Date:  2019-03-19       Impact factor: 9.867

Review 2.  Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.

Authors:  Asfar S Azmi; Bin Bao; Fazlul H Sarkar
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

3.  Semen exosomes inhibit HIV infection and HIV-induced proinflammatory cytokine production independent of the activation state of primary lymphocytes.

Authors:  Jennifer L Welch; Thomas M Kaufman; Jack T Stapleton; Chioma M Okeoma
Journal:  FEBS Lett       Date:  2019-12-02       Impact factor: 4.124

Review 4.  Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma.

Authors:  Abir Mondal; Divya Kumari Singh; Suchismita Panda; Anjali Shiras
Journal:  Front Oncol       Date:  2017-07-05       Impact factor: 6.244

5.  Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?

Authors:  Ana L Teixeira; Francisca Dias; Mónica Gomes; Mara Fernandes; Rui Medeiros
Journal:  J Kidney Cancer VHL       Date:  2014-12-24

Review 6.  Extracellular Vesicles in Glioblastoma Tumor Microenvironment.

Authors:  Anuroop Yekula; Anudeep Yekula; Koushik Muralidharan; Keiko Kang; Bob S Carter; Leonora Balaj
Journal:  Front Immunol       Date:  2020-01-21       Impact factor: 7.561

7.  Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma.

Authors:  Ngar Woon Kam; Ka Chun Wu; Wei Dai; Ying Wang; Leo Yik Chun Yan; Reshma Shakya; Rajiv Khanna; Yanru Qin; Simon Law; Anthony Wing Ip Lo; Victor Ho Fun Lee; Xin-Yuan Guan; Dora Lai-Wan Kwong
Journal:  Angiogenesis       Date:  2021-10-06       Impact factor: 9.596

8.  Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.

Authors:  Colin E Evans; Pär-Ola Bendahl; Mattias Belting; Cristina Branco; Randall S Johnson
Journal:  Blood       Date:  2015-12-23       Impact factor: 22.113

9.  Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells.

Authors:  Sujoy Dutta; Case Warshall; Chirosree Bandyopadhyay; Dipanjan Dutta; Bala Chandran
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

Review 10.  Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application.

Authors:  Shang-Long Liu; Pin Sun; Ying Li; Shi-Song Liu; Yun Lu
Journal:  Transl Cancer Res       Date:  2019-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.